DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the ...

Although Uganda participated in a groundbreaking trial for Lenacapavir—an injectable drug proven effective in preventing ...

The $400 million that the United States Congress removed from a list of programmes from which the Trump administration wants ...

WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...

Yeztugo, a twice yearly injection, offers a promising advancement in HIV prevention, but high costs and insurance uncertainties may limit its accessibility.

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

AIDS AND HIV, the virus that causes it, once sparked fear across the world. Apocalyptic forecasters in early 2002 reckoned that in some southern African countries half of new mothers would soon die of ...

The World Health Organisation (WHO) said more than 30 million children did not receive the full course of vaccines they ...

Medical professionals Timothy Holtz and Teri Mills worked with AIDS patients in the 1990s, when treatments were few. With ...